Table 2.
Linear associations between log-transformed serum PFAS and liver function biomarkers, NHANES 2003–2016 a,b
| Unadjusted | Model 1 c | Model 2 d | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β | 95% CI | P | β | 95% CI | P | β | 95% CI | P | |||||
|
| |||||||||||||
| ALT | PFOA | 1.09 | 0.74 | 1.43 | <0.0001 | 0.70 | 0.36 | 1.04 | <0.0001 | 0.87 | 0.49 | 1.25 | <0.0001 |
| PFOS | 0.49 | 0.21 | 0.78 | <0.0001 | 0.19 | −0.09 | 0.46 | 0.18 | 0.23 | −0.11 | 0.57 | 0.19 | |
| PFHxS | 0.92 | 0.64 | 1.19 | <0.0001 | 0.50 | 0.21 | 0.79 | 0.0008 | 0.62 | 0.33 | 0.92 | <0.0001 | |
| PFNA | 0.82 | 0.39 | 1.25 | <0.0001 | 0.53 | 0.14 | 0.93 | 0.01 | 0.66 | 0.25 | 1.08 | 0.002 | |
| PFDA | 0.09 | −0.26 | 0.45 | <0.0001 | 0.00 | 0.34 | 0.34 | 0.99 | 0.19 | −0.15 | 0.53 | 0.27 | |
| AST | PFOA | 0.71 | 0.39 | 1.02 | <0.0001 | 0.51 | 0.16 | 0.86 | 0.005 | 0.65 | 0.23 | 1.08 | 0.003 |
| PFOS | 0.17 | −0.05 | 0.40 | 0.13 | −0.07 | −0.31 | 0.16 | 0.54 | −0.13 | −0.44 | 0.17 | 0.38 | |
| PFHxS | 0.51 | 0.28 | 0.75 | <0.0001 | 0.28 | 0.02 | 0.53 | 0.03 | 0.32 | 0.05 | 0.59 | 0.02 | |
| PFNA | 0.35 | −0.002 | 0.71 | 0.05 | 0.18 | −0.19 | 0.55 | 0.005 | 0.22 | −0.19 | 0.63 | 0.29 | |
| PFDA | −0.02 | −0.33 | 0.28 | 0.89 | −0.11 | −0.42 | 0.21 | 0.50 | −0.08 | −0.42 | 0.26 | 0.63 | |
| ALP | PFOA | −0.02 | −0.60 | 0.56 | 0.96 | −0.04 | −0.70 | 0.62 | 0.91 | −0.52 | −1.22 | 0.18 | 0.15 |
| PFOS | 0.19 | −0.29 | 0.67 | 0.43 | −0.17 | −0.73 | 0.38 | 0.53 | −0.77 | −1.44 | −0.09 | 0.03 | |
| PFHxS | −0.17 | −0.55 | 0.20 | 0.37 | −0.43 | −0.84 | −0.01 | 0.04 | −0.47 | −0.86 | −0.08 | 0.02 | |
| PFNA | −0.09 | −0.77 | 0.59 | 0.79 | −0.31 | −1.03 | 0.41 | 0.39 | −0.40 | −1.12 | 0.33 | 0.28 | |
| PFDA | −0.73 | −1.34 | −0.12 | 0.02 | −0.92 | −1.55 | −0.30 | 0.004 | −0.92 | −1.53 | −0.32 | 0.003 | |
| GGT | PFOA | 1.81 | 0.70 | 2.92 | 0.002 | 1.36 | 0.14 | 2.58 | 0.03 | 1.63 | −0.06 | 3.32 | 0.06 |
| PFOS | 0.23 | −0.61 | 1.07 | 0.59 | −0.60 | −1.44 | 0.23 | 0.16 | −0.99 | −2.23 | 0.24 | 0.11 | |
| PFHxS | 0.27 | −0.41 | 0.95 | 0.43 | −0.41 | −1.25 | 0.44 | 0.35 | −0.33 | −1.29 | 0.63 | 0.49 | |
| PFNA | 1.23 | 0.05 | 2.41 | 0.04 | 0.54 | −0.75 | 1.82 | 0.41 | 0.72 | −0.80 | 2.24 | 0.35 | |
| PFDA | 0.11 | −0.82 | 1.03 | 0.82 | −0.34 | −1.29 | 0.61 | 0.48 | −0.08 | −1.17 | 1.01 | 0.88 | |
| TB | PFOA | 0.06 | 0.05 | 0.06 | <0.0001 | 0.04 | 0.03 | 0.05 | <0.0001 | 0.016 | 0.008 | 0.024 | 0.0001 |
| PFOS | 0.04 | 0.04 | 0.05 | <0.0001 | 0.03 | 0.03 | 0.04 | <0.0001 | 0.006 | 0.000 | 0.013 | 0.05 | |
| PFHxS | 0.04 | 0.03 | 0.05 | <0.0001 | 0.02 | 0.02 | 0.03 | <0.0001 | 0.014 | 0.008 | 0.021 | <0.0001 | |
| PFNA | 0.04 | 0.03 | 0.05 | <0.0001 | 0.03 | 0.03 | 0.04 | <0.0001 | 0.014 | 0.007 | 0.022 | 0.0003 | |
| PFDA | 0.04 | 0.03 | 0.04 | <0.0001 | 0.03 | 0.02 | 0.04 | <0.0001 | 0.011 | 0.003 | 0.018 | 0.007 | |
Perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), perfluorohexanesulfonic acid (PFHxS), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA)
Alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), total bilirubin (TB)
Adjusted for age, age2, gender and race/ethnicity
Adjusted for age, age2, gender, race/ethnicity, body mass index, poverty income ratio, education level, smoking status and survey cycle